Magnelis B6 forte Tablets p / o, 100 mg +10 mg, No. 30

Magnelis B6 forte tab.

p / o captivity.

100mg + 10mg No. 30

Name ENG

MAGNELIS B6 FORTE

Clinical and pharmacological group

A drug that replenishes magnesium deficiency in the body

ATX code

Magnesium preparations

Dosage

100mg + 10mg

Structure

1 tab.

active substances: magnesium citrate 618.43 mg, which corresponds to the content of magnesium (Mg2 +) 100 mg pyridoxine hydrochloride 10 mg

Indications

established magnesium deficiency, isolated or associated with other deficiency conditions, accompanied by symptoms such as increased irritability, minor sleep disturbances, gastrointestinal cramps, heart palpitations, increased fatigue, muscle pain and spasms, tingling sensation in the muscles.

If after a month of treatment there is no improvement in the symptoms of magnesium deficiency, continued treatment is impractical.

INN / Active ingredient

Pyridoxine + Magnesium Citrate

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 2 years

Contraindications

hypersensitivity to any component of the drug

- severe renal failure (CC < 30 ml / min) phenylketonuria age up to 12 years (efficacy and safety have not been established) hereditary galactosemia, glucose and galactose malabsorption syndrome or lactase deficiency (due to the presence of lactose in the preparation) simultaneous taking levodopa.

With care: moderate renal failure (risk of developing hypermagnesemia).

Application during pregnancy and lactation Clinical experience of using the drug in a sufficient number of pregnant women did not reveal any adverse effect on the occurrence of fetal malformations or fetotoxic effects

Specifications

Category

Vitamin and mineral complexes

Scope of the medicinal product

Vitamins

Release form

Tablet

Manufacturer country

Russia

Package quantity, pcs

thirty

Scope of application

Immunology

Minimum age from

12 years

Vacation conditions

Without recipe

Brand name

OTCPharm

The amount of the dosage form in the primary package

10 pieces.

Primary packaging type

Blister

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Magnesium drug

Anatomical and therapeutic characteristics

A12CC Magnesium preparations

Dosage form

Film-coated tablets

Packaging

Box

The target audience

Children

Expiration date in days

730

Package weight, g

40

Mode of application

:

The tablets should be taken whole with a glass of water. < br> Adults: 3-4 tablets / day, divided into 2-3 doses, with meals. < br> Children over the age of 12: 2-4 tablets / day , divided into 2-3 doses, with meals. < br> The duration of treatment is usually 1 month.

Dosage (volume) of the substance in the preparation

:

1 tablet: magnesium citrate 618.43 mg, which corresponds to the content of magnesium (Mg2 +) 100 mg pyridoxine hydrochloride 10 mg